|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Table 4: Characteristics of clinical features in consecutively studied prematures with severe ROP in whom combined therapy was applied. Case # - consecutive patients number, RDS-respiratory distress syndrome (I,II,III,IV RDS-stages of RDS), BPD-bronchopulmonary dysplasia, (+/0 – presence or absence of examined feature), IVH-intraventricular hemorrhage, Transfusion No.-number of transfusions, Ventilation-mechanical ventilation (number of days), NEC-enterocolitis necroticans, PDA-patent ductus arteriosus, L-DPA patent ductus arteriosus surgical ligation. |